| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.27(B) |
| Last
Volume: |
6,919,020 |
Avg
Vol: |
8,403,954 |
| 52
Week Range: |
$48.64 - $76.12 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
319,019 |
515,317 |
1,014,661 |
2,126,174 |
| Total Sell Value |
$23,643,548 |
$35,409,189 |
$61,747,133 |
$111,248,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
15 |
27 |
45 |
80 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pierce David A |
EVP Pres MedSurg |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$31,147 |
D/D |
(732) |
3,645 |
|
- |
|
| Pierce David A |
EVP Pres MedSurg |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,493 |
4,377 |
|
- |
|
| Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$41,018 |
D/D |
(964) |
92,360 |
|
- |
|
| Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
93,324 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Pres, Cardiology |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$81,824 |
D/D |
(1,923) |
216,047 |
|
- |
|
| Fitzgerald Joseph Michael |
EVP & Pres, Cardiology |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,895 |
217,970 |
|
- |
|
| Mackey Edward F |
EVP, Operations |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$51,443 |
D/D |
(1,209) |
51,584 |
|
- |
|
| Mackey Edward F |
EVP, Operations |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,726 |
52,793 |
|
- |
|
| Meredith Ian T |
EVP Global Chief Med Officer |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$12,680 |
D/D |
(298) |
33,951 |
|
- |
|
| Meredith Ian T |
EVP Global Chief Med Officer |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,013 |
34,249 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$36,550 |
D/D |
(859) |
140,773 |
|
- |
|
| Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,804 |
141,632 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$19,488 |
D/D |
(458) |
163,562 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,558 |
164,020 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$317,508 |
D/D |
(7,462) |
2,122,922 |
|
- |
|
| Mahoney Michael F |
Chairman, President & CEO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,825 |
2,130,384 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$69,101 |
D/D |
(1,624) |
272,826 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,661 |
274,450 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$25,232 |
D/D |
(593) |
176,192 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
176,785 |
|
- |
|
| Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$30,551 |
D/D |
(718) |
34,248 |
|
- |
|
| Butcher Arthur C |
EVP&Pres, Asia Pacific |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,714 |
34,966 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$7,659 |
D/D |
(180) |
30,742 |
|
- |
|
| Monson Jonathan |
VP, Global Controller and CAO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
623 |
30,922 |
|
- |
|
| Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
• • – |
2022-02-21 |
4 |
D |
$42.55 |
$11,701 |
D/D |
(275) |
25,035 |
|
- |
|
4540 Records found
|
|
Page 20 of 182 |
|
|
0.99 (1.3%) 
